Clinical Trials Directory

Trials / Completed

CompletedNCT05495178

Hepatobiliary Manifestations Following Two-Stages Elective Laparoscopic Restorative Proctocolectomy for Patients With Ulcerative Colitis. A Prospective Observational Study.

Status
Completed
Phase
Study type
Observational
Enrollment
167 (actual)
Sponsor
Zagazig University · Other Government
Sex
All
Age
18 Years – 69 Years
Healthy volunteers

Summary

Several studies using different methodological approach have revealed incomplete, old and conflicting data on the course of hepatobiliary manifestations after surgery. authors conducted a prospective observational study to evaluate the role of LRP on the course of hepatobiliary manifestations for a better knowledge of these manifestations that is necessary to improve their management.also, to evaluate the role of surgery on prevention of liver damage from progression of the disease.

Detailed description

Inflammatory bowel disease (IBD) prevalence is expected to reach 1% of the population in many regions over the next decade. despite the fact that the primary clinical manifestations of IBD are centred in the gastrointestinal tract, 25-40% of IBD patients develop at least one extraintestinal manifestation (EIM). Hepatobiliary manifestations constitute one of the most common EIMs in IBD . Hepatobiliary manifestations are much more commonly associated with ulcerative colitis (UC) and include primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), fatty liver, cholelithiasis, primary biliary cholangitis, portal vein thrombosis, and hepatic abscess. Most UC patients can be managed medically, but a minority requires proctocolectomy. Two-stage laparoscopic proctocolectomy (LPC) with ileal pouch-anal anastomosis (IPAA) is a cure for colitis, but its effect on hepatobiliary diseases is controversial.

Conditions

Interventions

TypeNameDescription
PROCEDURElaparoscopic restorative proctocolectomylaparoscopic restorative proctocolectomy

Timeline

Start date
2013-06-01
Primary completion
2018-06-01
Completion
2022-06-01
First posted
2022-08-10
Last updated
2022-10-13

Source: ClinicalTrials.gov record NCT05495178. Inclusion in this directory is not an endorsement.